Jason Paul Steik
Chief Clinical Officer · Pennant Group, Inc.
- 2026
- Aug 10, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jason Paul Steik files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Brent Guerisoli - $583K in PNTG purchases and sales in the last 12 months
- Kirk Sterling Cheney - $54K in PNTG purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jason Paul Steik?
Jason Paul Steik is a corporate insider, tracked as Chief Clinical Officer of Pennant Group, Inc. (PNTG). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jason Paul Steik submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Jason Paul Steik been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($54K) across all tracked filings.
